摘要 |
Compounds and methods useful for treating and prevention of cancer, particularly hormone-dependent breast cancer. Provided are compounds of formula I: wherein X is selected from O, N, S, SO, SO<SUB>2</SUB>, and S(CH<SUB>2</SUB>)<SUB>n</SUB>, wherein n = 1 - 10; R<SUB>1</SUB> and R<SUB>2</SUB> may be the same or different and are selected from H, OH, OCH<SUB>3</SUB>, OCH<SUB>2</SUB>CH<SUB>3</SUB>, OCH<SUB>2</SUB>C<SUB>6</SUB>H<SUB>5</SUB>, NH<SUB>2</SUB>, NHCH<SUB>3</SUB>, N(CH<SUB>3</SUB>)<SUB>2</SUB>, CH<SUB>3</SUB>, CH<SUB>2</SUB>CH<SUB>3</SUB>, CH<SUB>2</SUB>CH<SUB>2</SUB>CH<SUB>3</SUB>, CH(CH<SUB>3</SUB>)<SUB>2</SUB>, C(CH<SUB>3</SUB>)<SUB>3</SUB>, NO<SUB>2</SUB>, F, Cl, Br, CF<SUB>3</SUB>, SH, SCH<SUB>3</SUB>, SCH<SUB>2</SUB>CH<SUB>3</SUB>, OCOCH<SUB>3</SUB>, OCOC(CH<SUB>3</SUB>)<SUB>3</SUB>, OCOCH<SUB>2</SUB>COOH, and CN; and R<SUB>3</SUB> is a nitrogen-containing heterocyclic ring. Also provided are method for treating or preventing cancer in a subject by administering a therapeutically effective amount of a heteroaryl-containing isoflavone, or a pharmaceutically acceptable salt or prodrug thereof, to a subject in need of treatment. Also provided is a method for the synthesis of 2-substituted isoflavones by first reacting deoxybenzoins with a phase transfer catalyst to provide a 2-(alkylthio)isoflavone; second deprotecting the 2-(alkylthio)isoflavone; and third applying selective debenzylation to form the final compound.
|
申请人 |
THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION;BRUEGGEMEIER, ROBERT W.;KIM, YOUNG-WOO;HACKETT, JOHN C. |
发明人 |
BRUEGGEMEIER, ROBERT W.;KIM, YOUNG-WOO;HACKETT, JOHN C. |